Chugai Pharmaceutical Co Financial Overview
Chugai Pharmaceutical Co's market cap is currently $86.34B. The company's EPS TTM is $0.49288629000000006; its P/E ratio is 32.43; and it has a dividend yield of 2.34%. Chugai Pharmaceutical Co is scheduled to report earnings on October 24, 2025, and the estimated EPS forecast is $0.48. See an overview of income statement, balance sheet, and cash flow financials.
